Rate of Future Hemolytic Disease of the Fetus and Newborn Following the Prehospital Transfusion of RhD-Positive Blood Products to Females of Childbearing Potential in the United States of America.
Prehospital Emergency Care · 2026-09-10 · Method & validation
Abstract
OBJECTIVES: Transfusing females of childbearing potential (FCP) in hemorrhagic shock with RhD-positive blood products risks inducing the formation of anti-D that can cause hemolytic disease of the fetus and newborn (HDFN) in future pregnancies. A previous study found that 957 FCPs were transfused with RhD-positive blood products over approximately 5-years in the United States (U.S.) in the prehospital phase of their resuscitation. This study used an in silico simulation to calculate the rate of future HDFN amongst these 957 transfused FCPs. METHODS: A model that calculated the overall risk of any severity of HDFN was updated with the most current nativity data in the U.S. population. The model first simulated 1,000 FCPs of unknown RhD type at each age between 12-50 years to determine their age-specific rate of future HDFN. This model was instantiated 500 times representing a total of 19.5 million simulated FCPs. The model then used the IQR of the median ages of the 957 transfused FCPs, stratified by U.S. geographic region, to simulate the future HDFN outcomes of these FCPs. This model was instantiated 500 times representing approximately 2,500 years. RESULTS: The maximum rate of HDFN for FCPs of unknown RhD type was approximately 0.8% and occurred when the FCPs were between ages 18-20 years. The risk of future HDFN for the 957 RhD-type unknown transfused FCPs ranged from 0.214% (Northeast) to 0.294% (South) per year. Over this 2,500 year simulation a total of 1,368 HDFN cases were calculated to occur (0.55 per year). The number of prehospital transfused FCPs was not equal between the geographic regions and ranged between 29 (Northeast) to 710 (South) every 5-years. Thus, based on the historical trends in these four geographic regions, one case of HDFN would be expected to occur every approximately 2.4- to 80.7-years depending on the geographic region. CONCLUSIONS: Due to the generally advanced maternal age of the 957 transfused FCPs and their low probability of being RhD-negative, the risk of future HDFN because of urgent prehospital RhD-positive transfusion is low.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Blood products · Fluids & blood
Related articles
- Post-Transfusion Management of RhD-Negative Females of Childbearing Potential Who Receive RhD-Positive Low-Titer Group O Whole Blood and Red Blood Cells During Trauma Resuscitation: A Joint Position Statement and Resource Document of the American College of Surgeons Committee on Trauma (ACS-COT), Prehospital Blood Transfusion Coalition (PBTC), National Association of Emergency Medical Services Physicians (NAEMSP), Trauma Hemostasis and Oxygenation Research (THOR) Network, and Allo Hope Foundation (AHF). (J Am Coll Surg, 2026)
- Emergent Transfusion and Hemolytic Disease of the Fetus and Newborn Risk Mitigation in Females of Childbearing Potential with Life-Threatening Bleeding: A Clinical Practice Guideline. (J Am Coll Surg, 2026)
- Prehospital Trauma Compendium: Transfusion of Blood Products in Trauma - A Position Statement and Resource Document of NAEMSP. (Prehosp Emerg Care, 2025)
- RhD-Positive Transfusion in Females of Childbearing Potential in Hemorrhagic Shock: Risk, Reality, and Policy. (Prehosp Emerg Care, 2026)
- Prehospital whole-blood transfusion in two countries: comparison of patient characteristics in Sweden and the Northeastern United States. (Eur J Trauma Emerg Surg, 2026)
- Nationwide estimates of potential lives saved with prehospital blood transfusions. (Transfusion, 2025)